Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 6000
Single User License Price INR 413400
Corporate User License Price USD 18000
Corporate User License Price INR 1240200
Site License Price USD 12000
Site License Price INR 826800
Request a Quote

Report Title

Digital Landscape: Rheumatoid Arthritis

Quote Request for License Type
License Type Price  
Single User License USD 6000
Site License USD 12000
Enterprise Wide License USD 18000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Digital Landscape: Rheumatoid Arthritis


Quote Request for License Type
License Type Price  
Single User License USD 6000
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Digital Landscape: Rheumatoid Arthritis

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Digital Landscape: Rheumatoid Arthritis



Executive Summary

Digital Landscape: Rheumatoid Arthritis

Summary

The Digital Landscape Rheumatoid Arthritis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe rheumatoid arthritis (RA).

Key Highlights

- US Patients: AbbVie offers the strongest support for RA patients in the US, particularly branded, unbranded and mobile app. Branded activity seen from Janssen with its counter-biosimilar campaign for Remicade, while new advertising campaigns seen for Enbrel and Xeljanz. Sanofi entered the space for the first time following approval of Kevzara. Opportunity exists for a well-integrated unbranded campaign to support patients, linked to social media and a mobile app.

- US HCPs: Good branded support available for US HCPs in the RA space. Sanofi launched a HCP site for Kevzara, supported by high paid advertising spend. Branded activity also detected from AbbVie, BMS, as well as biosimilar manufacturer Pfizer. Unbranded and mobile app landscapes are sparse. Opportunities may exist to develop or sponsor content with trusted non-pharma organizations. Social media activity restricted to corporate accounts.

- EUCAN Patients: Good branded support is available for RA patients in Germany, the UK, and Canada. No multi-country, local-language unbranded campaigns detected, with good examples of local sites seen, and support strongest from Roche / Chugai overall. Social media support limited to country-specific pages in Spain and France, RA patients have access to good mobile app offerings, however none detected in Spain or Italy.

- EUCAN HCPs: The EUCAN HCP landscape is underdeveloped, with little activity seen past branded. New brand activity seen for Xeljanz and Olumiant. The unbranded and mobile app landscapes are particularly sparse, and partnerships with non-pharma organizations may offer more effective opportunities to engage with and support HCPs.

Scope

- This report analyzes digital activities undertaken by pharma in support of therapies for therapies for moderate-to-severe rheumatoid arthritis (RA).

- The report includes digital activities directed towards patients and/or HCPs, including branded websites, unbranded disease awareness initiatives, social media and mobile apps.

- The report is based on analysis conducted by a combination of GlobalData's digital and disease-specific teams. It also includes analysis of data licensed from third parties e.g. website traffic, search engine optimization (SEO), digital display advertising, mobile app downloads, and social media interaction.

- The geographic scope of the report is the United States, Canada and the 5EU (UK, Germany, France, Italy & Spain), with EUCAN used as an abbreviation for Europe and Canada throughout.

- This report covers the research period from January-December 2017.

Reasons to buy

- Our Digital Landscape report provides an analysis of pharma multichannel activity in the digital RA space, and can assist our pharma clients derive value in a number of ways:

- Competitive Intelligence: Track and compare key competitor activity across channels and identify key trends in RA

- Digital Strategy: Strengthen corporate digital excellence, learn from industry best practice, and identify opportunities for novel digital campaigns

- Support new brand launch: See best practice examples of pre- and post-launch digital activities, ascertain must-have digital assets for patient and HCP engagement, and assess potential gaps and opportunities for pipeline brands

- Business Development & Licensing: Assess topics and trends shaping digital health in RA and beyond, and learn about key patient and physician online activities in RA.

Table of Contents

Executive Summary

Recent Developments

Landscape & Analysis

US: Patient-directed Activities

US HCP-directed Activities

EUCAN Patient-directed Activities

EUCAN HCP-directed Activities

Methodology

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

AbbVie

Janssen

Pfizer

Roche / Genentech / Chugai

BMS

Sanofi Genzyme / Regeneron

Amgen

UCB

MSD / Merck

Eli Lilly

Sandoz

Biogen


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person